首页> 外文期刊>Hematology >Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia
【24h】

Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia

机译:共刺激分子B7-H3的表达及其在人类急性白血病中的预后意义

获取原文
           

摘要

Objectives This study focused on the expression pattern and clinical significance of B7-H3 expression in human acute leukemia. Methods We systematically analyzed 134 patients with acute myeloid leukemia (101 cases) and acute lymphocytic leukemia (33 cases) by flow cytometry. Results The frequency of B7-H3sup+/sup cases was 44.8% in total. The B7-H3 expression rate differed from 0% to 74.8% in individual cases. The correlation between B7-H3 expression and traditional prognostic factors, such as age and gender, the white blood cell count was not confirmed. However, B7-H3 had a significant higher expression in CD34sup+/sup cases and high risk karyotypes. Conclusions Owing to the expression of B7-H3 being statistically relevant in predicting disease progression and a shorter life survival, our results demonstrated that B7-H3 expression in acute leukemia predicts an unfavorable outcome.
机译:目的本研究集中于人急性白血病中B7-H3的表达模式及其临床意义。方法我们通过流式细胞术系统分析了134例急性髓细胞性白血病(101例)和急性淋巴细胞性白血病(33例)。结果B7-H3 + 病例的总数为44.8%。在个别情况下,B7-H3表达率从0%到74.8%不等。 B7-H3表达与传统的预后因素,如年龄和性别,白细胞计数之间没有相关性。然而,B7-H3在CD34 + 病例和高危核型中有较高的表达。结论由于B7-H3的表达在预测疾病进展和缩短生存期方面具有统计学意义,因此我们的结果表明,急性白血病中B7-H3的表达预示了不良的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号